Samsung becomes largest shareholder in Element Biosciences with US$175 mln investment

Samsung Electronics has become the largest shareholder in Element Biosciences, a U.S.-based life sciences company, following a significant investment of $175 million. This strategic move positions Samsung to expand its presence in the rapidly growing biotechnology sector. Element Biosciences specializes in developing innovative technologies for genomic sequencing.

This investment signals Samsung's ambition to diversify its business portfolio beyond traditional electronics and enter the competitive biotech market.